(Q36631350)

15 August 2017

Cancer vaccines and immunotherapeutics: challenges for pricing, reimbursement and market access (English)

1 reference

15 August 2017

1 reference

Bengt Jönsson

1

1 reference

PMC publication ID

3579921

15 August 2017

Nils Wilking

series ordinal

2

1 reference

15 August 2017

24 August 2012

1 reference

Human Vaccines & Immunotherapeutics

15 August 2017

1 reference

15 August 2017

8

1 reference

15 August 2017

9

1 reference

15 August 2017

1360-1363

1 reference

The cost effectiveness of human papillomavirus vaccines: a systematic review

15 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579921

Current vaccination strategies for prostate cancer

30 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579921

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

30 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579921

Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases: the BEST study

30 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FHV.21921

Do oncologists believe new cancer drugs offer good value?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FHV.21921

21 January 2018

Identifiers

DOI

10.4161/HV.21921

1 reference

15 August 2017

1 reference

PMC publication ID

3579921

15 August 2017

PubMed publication ID

22922209

1 reference

PMC publication ID

3579921